PFC
ICPT

Phocas Financial Corp’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Phocas Financial Corp’s Portfolio ICPT Stock Details ICPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-30,207
Closed -$1.25M – 208
2020
Q3 		$1.25M Buy
30,207
+990
+3% +$45.5K 0.22% 123
2020
Q2 		$1.4M Buy
29,217
+11,815
+68% +$913K 0.25% 121
2020
Q1 		$1.09M Sell
17,402
-1,512
-8% -$136K 0.22% 126
2019
Q4 		$2.34M Buy
+18,914
New +$1.69M 0.28% 116

Other funds holding ICPT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Phocas Financial Corp's ICPT Position: Q4 2020 in Review

Phocas Financial Corp sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q4 2020, closing a stake of 30,207 shares — an estimated $1.25M sold.

Phocas Financial Corp first reported a position in ICPT in Q4 2019 and held it in 4 quarters. The position peaked at $2.34M in Q4 2019. 175 funds tracked by Wall St. Rank hold ICPT as of Q4 2020.

  • Phocas Financial Corp reported no remaining Intercept Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • Phocas Financial Corp sold 30,207 Intercept Pharmaceuticals, Inc. shares in Q4 2020, an estimated $1.25M.
  • Phocas Financial Corp first reported a position in Intercept Pharmaceuticals, Inc. in Q4 2019 and held it in 4 quarters.
  • Phocas Financial Corp's Intercept Pharmaceuticals, Inc. position peaked at $2.34M in Q4 2019.
  • 175 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q4 2020.

Based on Phocas Financial Corp's 13F filing for Q4 2020, filed 16 Feb 2021.